Long-Term Outcomes in Patients with Advanced Urothelial Carcinoma (Uc) Who Received Avelumab First-Line (1 L) Maintenance with or Without Second-Line (2 L) Treatment: Exploratory Analyses from Javelin Bladder 100
AuthID
P-00X-FFC
P-00X-FFC